The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Open accessAbstract
BACKGROUND: This review is an update of 'Topical capsaicin (high concentration) for chronic neuropathic pain in adults' last updated in Issue 2, 2013. Topical creams with capsaicin are used to treat peripheral neuropathic pain. Following application to the skin, capsaicin causes enhanced sensitivity, followed by a period with reduced sensitivity and, after repeated applications, persistent desensitisation. High-concentration (8%) capsaicin patches were developed to increase the amount of capsaicin delivered; rapid delivery was thought to improve tolerability because cutaneous nociceptors are 'defunctionalised' quickly. The single application avoids noncompliance. Only the 8% patch formulation of capsaicin is available, with a capsaicin concentration about 100 times greater than conventional creams. High-concentration topical capsaicin is given as a single patch application to the affected part. It must be applied under highly controlled conditions, often following local anaesthetic, due to the initial intense burning sensation it causes. The benefits are expected to last for about 12 weeks, when another application might be made. OBJECTIVES: To review the evidence from controlled trials on the efficacy and tolerability of topically applied, high-concentration (8%) capsaicin in chronic neuropathic pain in adults. SEARCH METHODS: For this update, we searched CENTRAL, MEDLINE, Embase, two clinical trials registries, and a pharmaceutical company's website to 10 June 2016. SELECTION CRITERIA: Randomised, double-blind, placebo-controlled studies of at least 6 weeks' duration, using high-concentration (5% or more) topical capsaicin to treat neuropathic pain. DATA COLLECTION AND ANALYSIS: Two review authors independently searched for studies, extracted efficacy and adverse event data, and examined issues of study quality and potential bias. Where pooled analysis was possible, we used dichotomous data to calculate risk ratio and numbers needed to treat for one additional event, using standard methods.Efficacy outcomes reflecting long-duration pain relief after a single drug application were from the Patient Global Impression of Change (PGIC) at specific points, usually 8 and 12 weeks. We also assessed average pain scores over weeks 2 to 8 and 2 to 12 and the number of participants with pain intensity reduction of at least 30% or at least 50% over baseline, and information on adverse events and withdrawals.We assessed the quality of the evidence using GRADE and created a 'Summary of findings' table. MAIN RESULTS: We included eight studies, involving 2488 participants, two more studies and 415 more participants than the previous version of this review. Studies were of generally good methodological quality; we judged only one study at high risk of bias, due to small size. Two studies used a placebo control and six used 0.04% topical capsaicin as an 'active' placebo to help maintain blinding. Efficacy outcomes were inconsistently reported, resulting in analyses for most outcomes being based on less than complete data.For postherpetic neuralgia, we found four studies (1272 participants). At both 8 and 12 weeks about 10% more participants reported themselves much or very much improved with high-concentration capsaicin than with 'active' placebo, with point estimates of numbers needed to treat for an additional beneficial outcome (NNTs) of 8.8 (95% confidence interval (CI) 5.3 to 26) with high-concentration capsaicin and 7.0 (95% CI 4.6 to 15) with 'active' placebo (2 studies, 571 participants; moderate quality evidence). More participants (about 10%) had average 2 to 8-week and 2 to 12-week pain intensity reductions over baseline of at least 30% and at least 50% with capsaicin than control, with NNT values between 10 and 12 (2 to 4 studies, 571 to 1272 participants; very low quality evidence).For painful HIV-neuropathy, we found two studies (801 participants). One study reported the proportion of participants who were much or very much improved at 12 weeks (27% with high-concentration capsaicin and 10% with 'active' placebo). For both studies, more participants (about 10%) had average 2 to 12-week pain intensity reductions over baseline of at least 30% with capsaicin than control, with an NNT of 11 (very low quality evidence).For peripheral diabetic neuropathy, we found one study (369 participants). It reported about 10% more participants who were much or very much improved at 8 and 12 weeks. One small study of 46 participants with persistent pain following inguinal herniorrhaphy did not show a difference between capsaicin and placebo for pain reduction (very low quality evidence).We downgraded the quality of the evidence for efficacy outcomes by one to three levels due to sparse data, imprecision, possible effects of imputation methods, and susceptibility to publication bias.Local adverse events were common, but not consistently reported. Serious adverse events were no more common with active treatment (3.5%) than contro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Self-citationDworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
GRADE guidelines: 7. Rating the quality of evidence—inconsistency
Guyatt, G. H., Oxman, A. D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Glasziou, P., Jaeschke, R., Akl, E. A., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.03.017 · Cited by 2,320
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Neuropathic pain in the general population: A systematic review of epidemiological studies
van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014) · Pain · doi:10.1016/j.pain.2013.11.013 · Cited by 1,602
The visual analogue pain intensity scale: what is moderate pain in millimetres?
Collins, S. L., Moore, A. R., & McQuay, H. J. (1997) · Pain · doi:10.1016/s0304-3959(97)00005-5 · Cited by 1,543
Self-citationA new definition of neuropathic pain
Jensen, T. S., Baron, R., Haanpää, M., Kalso, E., Loeser, J. D., Rice, A. S. C., & Treede, R.-D. (2011) · Pain · doi:10.1016/j.pain.2011.06.017 · Cited by 1,427
Self-citation(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
Guyatt, G. H., Oxman, A. D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Norris, S., Meerpohl, J., Djulbegovic, B., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.012 · Cited by 836
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 800
Morris, J. A., & Gardner, M. J. (1988) · BMJ · doi:10.1136/bmj.296.6632.1313 · Cited by 764
Guyatt, G., Oxman, A. D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Kunz, R., Montori, V., Jaeschke, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.006 · Cited by 762
Pregabalin for acute and chronic pain in adults
Moore, R. A., Straube, S., Wiffen, P. J., Derry, S., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub2 · Cited by 762
Self-citationAnand, P., & Bley, K. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer260 · Cited by 700
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Self-citationBril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Moore, A. R., Gavaghan, D., Tramèr, R. M., Collins, L. S., & McQuay, J. H. (1998) · Pain · doi:10.1016/s0304-3959(98)00140-7 · Cited by 604
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Lunn, M. P., Hughes, R. A., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007115.pub3 · Cited by 565
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559
Influence of trial sample size on treatment effect estimates: meta-epidemiological study
Dechartres, A., Trinquart, L., Boutron, I., & Ravaud, P. (2013) · BMJ · doi:10.1136/bmj.f2304 · Cited by 544
Incidence of facial pain in the general population
Koopman, J. S. H. A., Dieleman, J. P., Huygen, F. J., de Mos, M., Martin, C. G. M., & Sturkenboom, M. C. J. M. (2009) · Pain · doi:10.1016/j.pain.2009.08.023 · Cited by 489
Systematic review of topical capsaicin for the treatment of chronic pain
Mason, L., Moore, R. A., Derry, S., Edwards, J. E., & McQuay, H. J. (2004) · BMJ · doi:10.1136/bmj.38042.506748.ee · Cited by 462
Self-citationQuantitive systematic review of topically applied non-steroidal anti-inflammatory drugs
Moore, R. A., Tramer, M. R., Carroll, D., Wiffen, P. J., & McQuay, H. J. (1998) · BMJ · doi:10.1136/bmj.316.7128.333 · Cited by 446
Self-citationThe role of the immune system in the generation of neuropathic pain
Calvo, M., Dawes, J. M., & Bennett, D. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70134-5 · Cited by 445
Demant, D. T., Lund, K., Vollert, J., Maier, C., Segerdahl, M., Finnerup, N. B., Jensen, T. S., & Sindrup, S. H. (2014) · Pain · doi:10.1016/j.pain.2014.08.014 · Cited by 440
Backonja, M., Wallace, M. S., Blonsky, E. R., Cutler, B. J., Malan, P., Rauck, R., & Tobias, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70228-x · Cited by 424
Epidemiology and treatment of neuropathic pain: The UK primary care perspective
Hall, G. C., Carroll, D., Parry, D., & McQuay, H. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.030 · Cited by 379
Andrew, R., Derry, S., Taylor, R. S., Straube, S., & Phillips, C. J. (2014) · Pain Practice · doi:10.1111/papr.12050 · Cited by 375
Self-citation“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370
Self-citationKatusic, S., Williams, D. B., Beard, M., Bergstralh, E. J., & Kurland, L. T. (1991) · Neuroepidemiology · doi:10.1159/000110284 · Cited by 367
Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome
Moore, R. A., Straube, S., & Aldington, D. (2013) · Anaesthesia · doi:10.1111/anae.12148 · Cited by 362
Statistics with Confidence: Confidence Intervals and Statistical Guidelines
Hill, D. W. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.2.128-a · Cited by 334
Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial
Watson, C. P. N., Vernich, L., Chipman, M., & Reed, K. (1998) · Neurology · doi:10.1212/wnl.51.4.1166 · Cited by 319
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
Simpson, D. M., Brown, S., & Tobias, J. (2008) · Neurology · doi:10.1212/01.wnl.0000314647.35825.9c · Cited by 308
Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews
Wiffen, P. J., Derry, S., Moore, R. A., Aldington, D., Cole, P., Rice, A. S., Lunn, M. P., Hamunen, K., Haanpaa, M., & Kalso, E. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010567.pub2 · Cited by 306
Self-citationTrigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglion
Rappaport, H. Z., & Devor, M. (1994) · Pain · doi:10.1016/0304-3959(94)90086-8 · Cited by 303
Amitriptyline for neuropathic pain and fibromyalgia in adults
Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008242.pub2 · Cited by 293
Self-citationGabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & Rice, A. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub3 · Cited by 292
Self-citationSultan, A., Gaskell, H., Derry, S., & Moore, R. A. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-29 · Cited by 291
Self-citationTopical capsaicin treatment of chronic postherpetic neuralgia
Bernstein, J. E., Korman, N. J., Bickers, D. R., Dahl, M. V., & Millikan, L. E. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70171-7 · Cited by 289
Developing a database of published reports of randomised clinical trials in pain research 1
Jadad, A. R., Carroll, D., Moore, A., & McQuay, H. (1996) · Pain · doi:10.1016/0304-3959(96)03033-3 · Cited by 271
Self-citationExpect analgesic failure; pursue analgesic success
Moore, A., Derry, S., Eccleston, C., & Kalso, E. (2013) · BMJ · doi:10.1136/bmj.f2690 · Cited by 271
Self-citationGUSTORFF, B., DORNER, T., LIKAR, R., GRISOLD, W., LAWRENCE, K., SCHWARZ, F., & RIEDER, A. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2007.01486.x · Cited by 266
Sando, S. B., Melquist, S., Cannon, A., Hutton, M. L., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. O. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-9 · Cited by 261
Phillips, T. J. C., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014433 · Cited by 255
Self-citationN. WATSON, C. P., TYLER, K. L., BICKERS, D. R., MILLIKAN, L. E., SMITH, S., & COLEMAN, E. (1994) · Survey of Anesthesiology · doi:10.1097/00132586-199404000-00039 · Cited by 255
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Derry, S., Rice, A. S. C., Cole, P., Tan, T., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub3 · Cited by 247
Self-citationPost-herpetic neuralgia and topical capsaicin
Watson, P. N. C., Evans, R. J., & Watt, V. R. (1988) · Pain · doi:10.1016/0304-3959(88)90292-8 · Cited by 241
Health Care Needs Assessment: The Epidemiologically Based Needs Assessment Reviews
(2018) · CRC Press eBooks · doi:10.1201/9781315384719 · Cited by 229
Rains, C., & Bryson, H. M. (1995) · Drugs & Aging · doi:10.2165/00002512-199507040-00007 · Cited by 224
Moore, R. A., Derry, S., Makinson, G. T., & McQuay, H. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1704 · Cited by 223
Self-citationThe Prevalence and Impact of Chronic Pain with Neuropathic Pain Symptoms in the General Population
Toth, C., Lander, J., & Wiebe, S. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00655.x · Cited by 209
Sadosky, A., McDermott, A. M., Brandenburg, N. A., & Strauss, M. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2007.00164.x · Cited by 197
Patient-Centered Perspective on Treatment Outcomes in Chronic Pain
O'Brien, E. M., Staud, R. M., Hassinger, A. D., McCulloch, R. C., Craggs, J. G., Atchison, J. W., Price, D. D., & Robinson, M. E. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00685.x · Cited by 193
McCleane, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00200.x · Cited by 191
Simpson, D. M., Robinson-Papp, J., Van, J., Stoker, M., Jacobs, H., Snijder, R. J., Schregardus, D. S., Long, S. K., Lambourg, B., & Katz, N. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2016.09.008 · Cited by 181
Moore, A. R., Straube, S., Eccleston, C., Derry, S., Aldington, D., Wiffen, P., Bell, R. F., Hamunen, K., Phillips, C., & McQuay, H. (2012) · Pain · doi:10.1016/j.pain.2011.10.004 · Cited by 179
Self-citationTopical capsaicin for chronic neuropathic pain in adults
Derry, S., Lloyd, R., Moore, R. A., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub2 · Cited by 177
Self-citationTopical lidocaine for neuropathic pain in adults
Derry, S., Wiffen, P. J., Moore, A., & Quinlan, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010958.pub2 · Cited by 175
Self-citationIrving, G. A., Backonja, M. M., Dunteman, E., Blonsky, E. R., Vanhove, G. F., Lu, S.-P., Tobias, J., & NGX-4010 C117 Study Group (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2010.01004.x · Cited by 174
Hall, G. C., Carroll, D., & McQuay, H. J. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-26 · Cited by 174
Hoffman, D. L., Sadosky, A., Dukes, E. M., & Alvir, J. (2010) · Pain · doi:10.1016/j.pain.2009.09.017 · Cited by 173
Topical capsaicin (low concentration) for chronic neuropathic pain in adults
Derry, S., & Moore, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010111 · Cited by 173
Self-citationDuloxetine use in chronic painful conditions – individual patient data responder analysis
Moore, R. A., Cai, N., Skljarevski, V., & Tölle, T. R. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00341.x · Cited by 169
Self-citationEllison, N., Loprinzi, C. L., Kugler, J., Hatfield, A. K., Miser, A., Sloan, J. A., Wender, D. B., Rowland, K. M., Molina, R., Cascino, T. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2974 · Cited by 168
Reporting of Adverse Effects in Clinical Trials Should Be Improved
Edwards, J. E., McQuay, H. J., Moore, R. A., & Collins, S. L. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00093-7 · Cited by 167
Self-citationEffect of Treatment With Capsaicin on Daily Activities of Patients With Painful Diabetic Neuropathy
Capsaicin Study Group (1992) · Diabetes Care · doi:10.2337/diacare.15.2.159 · Cited by 164
Bouhassira, D., Chassany, O., Gaillat, J., Hanslik, T., Launay, O., Mann, C., Rabaud, C., Rogeaux, O., & Strady, C. (2012) · Pain · doi:10.1016/j.pain.2011.10.026 · Cited by 163
Yawn, B. P., Wollan, P. C., Weingarten, T. N., Watson, J. C., Hooten, W. M., & Melton, L. J. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00588.x · Cited by 160
Backonja, M. M., Malan, T. P., Vanhove, G. F., & Tobias, J. K. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00793.x · Cited by 157
Treatment of Intractable Pain with Topical Large-Dose Capsaicin
Robbins, W. R., Staats, P. S., Levine, J. D., Fields, H. L., Allen, R. W., Campbell, J. N., & Pappagallo, M. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199803000-00027 · Cited by 156
The postmastectomy pain syndrome and topical capsaicin: a randomized trial
Watson, P. N. C., & Evans, R. J. (1992) · Pain · doi:10.1016/0304-3959(92)90223-x · Cited by 149
The post-mastectomy pain syndrome and the effect of topical capsaicin
Watson, P. N. C., Evans, R. J., & Watt, V. R. (1989) · Pain · doi:10.1016/0304-3959(89)90236-4 · Cited by 144
Moore, R. A., Gaskell, H., Rose, P. E., & Allan, J. (2011) · BMC Blood Disorders · doi:10.1186/1471-2326-11-4 · Cited by 142
Self-citationPrevalence and comorbidity of chronic pain in the German general population
Ohayon, M. M., & Stingl, J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.001 · Cited by 139
Reporting of adverse drug reactions in randomised controlled trials – a systematic survey
Loke, Y. K., & Derry, S. (2001) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-1-3 · Cited by 138
Self-citationPregabalin in fibromyalgia - responder analysis from individual patient data
Straube, S., Derry, S., Moore, R. A., Paine, J., & McQuay, H. J. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-150 · Cited by 131
Self-citationPregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports
Straube, S., Derry, S., Moore, R. A., & McQuay, H. J. (2010) · Rheumatology · doi:10.1093/rheumatology/kep432 · Cited by 130
Self-citationTopical Capsaicin in the Management of HIV-Associated Peripheral Neuropathy
Paice, J. A., Ferrans, C. E., Lashley, F. R., Shott, S., Vizgirda, V. M., & PITRAK, D. L. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00139-6 · Cited by 128
van Nooten, F. E., Treur, M., Pantiri, K., Stoker, M., & Charokopou, M. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.02.010 · Cited by 122
Biesbroeck, R., Bril, V., Hollander, P. A., Kabadi, U. M., Schwartz, S., Singh, S. P., Wk, W., & Bernstein, J. E. (1995) · PubMed · Cited by 118
Kalso, E. A., Aldington, D. J., & Moore, R. A. (2013) · BMJ · doi:10.1136/bmj.f7339 · Cited by 115
Self-citationThe economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal
Azevedo, L. F., Costa‐Pereira, A., Mendonça, L., Dias, C. C., & Castro‐Lopes, J. M. (2014) · The European Journal of Health Economics · doi:10.1007/s10198-014-0659-4 · Cited by 115
Hall, G. C., Morant, S. V., Carroll, D., Gabriel, Z., & McQuay, H. J. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-28 · Cited by 107
Clifford, D. B., Simpson, D. M., Brown, S., Moyle, G. J., Brew, B. J., Conway, B., Tobias, J. K., & Vanhove, G. F. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823e31f7 · Cited by 98
Mou, J., Paillard, F., Turnbull, B. A., Trudeau, J., Stoker, M., & Katz, N. P. (2013) · Pain · doi:10.1016/j.pain.2013.04.044 · Cited by 97
Webster, L. R., Malan, T. P., Tuchman, M. M., Mollen, M. D., Tobias, J. K., & Vanhove, G. F. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.01.270 · Cited by 88
Peikert, A., Hentrich, M., & Ochs, G. (1991) · Journal of Neurology · doi:10.1007/bf00314653 · Cited by 84
Analgesic Effect of Capsaicin in Idiopathic Trigeminal Neuralgia
Fusco, B. M., & Alessandri, M. (1992) · Anesthesia & Analgesia · doi:10.1213/00000539-199203000-00011 · Cited by 78
Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain
Burness, C. B., & McCormack, P. L. (2015) · Drugs · doi:10.1007/s40265-015-0520-9 · Cited by 73
Capsaicin 8% Topical Patch (Qutenza)—A Review of the Evidence
Jones, V. M., Moore, K. A., & Peterson, D. M. (2011) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2010.547561 · Cited by 70
Neuropathic pain needs systematic classification
Finnerup, N. B., Scholz, J., Attal, N., Baron, R., Haanpää, M. L., Hansson, P. T., Raja, S. N., Rice, A. S. C., Rief, W., Rowbotham, M. C., et al. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00282.x · Cited by 70
Self-citationWolff, R. F., Bała, M. M., Westwood, M. E., Kessels, A. G. H., & Kleijnen, J. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01433.x · Cited by 67
Edelsberg, J., Lord, C., & Oster, G. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p777 · Cited by 63
Straube, S., Moore, R. A., Paine, J., Derry, S., Phillips, C. J., Hallier, E., & McQuay, H. J. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-125 · Cited by 61
Self-citationBrown, S., Simpson, D. M., Moyle, G. J., Brew, B. J., Schifitto, G., Larbalestier, N., Orkin, C. M., Fisher, M., Vanhove, G. F., & Tobias, J. K. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-5 · Cited by 58
Pharmacological Treatment of Diabetic Neuropathic Pain
Smith, H. S., & Argoff, C. E. (2011) · Drugs · doi:10.2165/11588940-000000000-00000 · Cited by 56
Individualized Pharmacological Treatment of Neuropathic Pain
Helfert, S. M., Reimer, M., Höper, J., & Baron, R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.19 · Cited by 45
High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
Üçeyler, N., & Sommer, C. (2014) · Pain and Therapy · doi:10.1007/s40122-014-0027-1 · Cited by 45
Chronic pain: genes, plasticity, and phenotypes
Baron, R., Wasner, G. L., & Binder, A. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70281-2 · Cited by 40
Moore, R. A., Derry, S., & McQuay, H. J. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2422 · Cited by 32
Self-citationIkenberg, R., Hertel, N., Moore, A., Obradović, M., Baxter, G., Conway, P., & Liedgens, H. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.670174 · Cited by 28
Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
Kern, K., Nowack, W., & Poole, C. (2013) · Pain Practice · doi:10.1111/papr.12143 · Cited by 20
Gülfe, A., Kristensen, L. E., Saxne, T., Jacobsson, L., Petersson, I. F., & Geborek, P. (2010) · Arthritis Care & Research · doi:10.1002/acr.20235 · Cited by 20
Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas
Ioannidis, J. P. A., & Lau, J. (2001) · JAMA · doi:10.1001/jama.285.4.437 · Cited by 3
Cited by
Chronic pain: an update on burden, best practices, and new advances
Cohen, S. P., Vase, L., & Hooten, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00393-7 · Cited by 2,614
International guidelines for groin hernia management
The HerniaSurge Group (2018) · Hernia · doi:10.1007/s10029-017-1668-x · Cited by 2,296
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Self-citationPaice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599
Metadata
- Authors
- Derry, S., Rice, A. S., Cole, P., Tan, T., & Moore, R. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-01-13
- Volume
- 2021
- Issue
- 7
- Pages
- CD007393-CD007393
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2134902551
- Cited by
- 559
- References
- 119
- FWCI
- 29.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.